INTERVIEWS

Steven Engle, CEO of CohBar, Inc, a clinical stage biotechnology company discusses his article in “Grit Daily” (Jan 8, 2021) on NASA’s breakthrough study published in “Cell” (Nov 25, 2020) on the effects of space travel on mitochondria.

Dr. Mike, a clinical psychologist discusses the podcast he is hosting called “Going There“. presented by Sound Mind Live and Consequences of Sound.  The weekly podcast aims to create a safe space for musicians to have honest, healthy conversations about mental health. Each episode covers the experience of artists and creatives as it pertains to specific issues, be it depression, anxiety, addiction, whatever they bring to the table. The goal is to de-stigmatize these topics and learn from each other.

Dr. Tania Gonzalez-Rivera, MD, BENLYSTA Global Medical Affairs Lead at GlaxoSmithKline (GSK) discusses the recent FDA approval of BENLYSTA (Belimumab) the first and only approved biologic treatment for both lupus and adult patients with active lupus nephritis who are receiving standard therapy. This approval builds on 10 years of clinical evidence. 

Dr. Ed Baker, FACOG, an OB/GYN and Senior Director, Medical Affairs, Cervical Cancer Solutions at Roche Molecular Diagnostics, discusses advanced biomarker technology that provides evidence and insights that simplify testing, find cervical cancer earlier, and give physicians more definitive information for confident diagnosis and decision-making. He talks about how this technology substantially lowers the risk of missed disease in HPV positive women and the critical role the medical lab plays in cervical cancer prevention.

Dr. Louis Aronne, MD, FACP, Chief Medical Officer of Intellihealth and medical director of the Comprehensive Weight Control Center at Weill Cornell, discusses the latest medical obesity treatment: Intellihealth’s Evolve — a technology platform for medically-supervised weight management.

There has been a drastic drop in breast and colorectal cancer screenings.  Hospitals that are overrun and overwhelmed have prolonged and, in many cases, halted the diagnosis and treatment of serious illness. Dr. Bhoomi Mehrotra, MD, Director of Oncology and Director of The Cancer Institute at St. Francis Hospital in NY, discusses how they are continuing to screen, diagnose and treat patients, and the importance of encouraging communities to not postpone their annual exams or checkups.

Dr. Ernest J. Grant, Ph.D., RN, FAAN, President of the American Nurses Association discusses the COVID-19 HCP vaccine education effort featuring a video series with healthcare professionals and an introduction from Dr. Anthony Fauci. This is a partnership with the Ad Council and the COVID Collaborative supported by 18 leading health organizations. He talks about why he got involved, ways nurses can best prepare to address patient questions about COVID-19 vaccination, and his personal experience in a COVID-19 clinical trial. The Q+A video is available on the Ad Council’s YouTube page.

Katherine Wilemon, founder of the Familial Hypercholesterolemia (FH) Foundation, who had a heart attack at age 39 due to undiagnosed and unmanaged FH, and Dr. Pamela Taub, an Associate Professor of Medicine in the Division of Cardiovascular Medicine at the University of California San Diego, discuss the risks associated with poorly managed cholesterol, risk factors for FH and treatment approaches that can make a difference for people who struggle to reach their cholesterol goals.

Lead author, Dr. Klaus Witte, Senior Lecturer and Consultant Cardiologist, University of Leeds and Leeds General Infirmary, discusses findings from a new economic study titled “Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke”.  Results were recently published in the Journal of Comparative Effectiveness Research.

Oncologist Dr. Tim Dorius shares how he provided a second opinion for a stage 4 lung cancer patient using Caris Life Sciences® full molecular profiling to identify the best treatment option.